Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect.

Cideciyan AV, Jacobson SG, Drack AV, Ho AC, Charng J, Garafalo AV, Roman AJ, Sumaroka A, Han IC, Hochstedler MD, Pfeifer WL, Sohn EH, Taiel M, Schwartz MR, Biasutto P, Wit W, Cheetham ME, Adamson P, Rodman DM, Platenburg G, Tome MD, Balikova I, Nerinckx F, Zaeytijd J, Van Cauwenbergh C, Leroy BP, Russell SR.

Nat Med. 2019 Feb;25(2):225-228. doi: 10.1038/s41591-018-0295-0. Epub 2018 Dec 17.

PMID:
30559420
2.

Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors.

van Duikeren S, Fransen MF, Redeker A, Wieles B, Platenburg G, Krebber WJ, Ossendorp F, Melief CJ, Arens R.

J Immunol. 2012 Oct 1;189(7):3397-403. Epub 2012 Aug 22.

3.

Systemic administration of PRO051 in Duchenne's muscular dystrophy.

Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling T, Janson AA, Platenburg GJ, Sipkens JA, Sitsen JM, Aartsma-Rus A, van Ommen GJ, Buyse G, Darin N, Verschuuren JJ, Campion GV, de Kimpe SJ, van Deutekom JC.

N Engl J Med. 2011 Apr 21;364(16):1513-22. doi: 10.1056/NEJMoa1011367. Epub 2011 Mar 23. Erratum in: N Engl J Med. 2011 Oct 6;365(14):1361.

4.

Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.

Mulders SA, van den Broek WJ, Wheeler TM, Croes HJ, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, Wieringa B, Wansink DG.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13915-20. doi: 10.1073/pnas.0905780106. Epub 2009 Aug 10.

5.

Exon skipping, a therapy for Duchenne muscular dystrophy. Interview by Guenter Scheuerbrandt.

Platenburg G.

Acta Myol. 2008 Oct;27:69-73. No abstract available.

PMID:
19364065
6.

Antisense-mediated exon skipping to correct IL-12Rbeta1 deficiency in T cells.

van de Vosse E, Verhard EM, de Paus RA, Platenburg GJ, van Deutekom JC, Aartsma-Rus A, van Dissel JT.

Blood. 2009 May 7;113(19):4548-55. doi: 10.1182/blood-2008-12-196220. Epub 2009 Mar 3. Erratum in: Blood. 2009 Nov 12;114(20):4607.

7.

In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.

Heemskerk HA, de Winter CL, de Kimpe SJ, van Kuik-Romeijn P, Heuvelmans N, Platenburg GJ, van Ommen GJ, van Deutekom JC, Aartsma-Rus A.

J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288.

PMID:
19140108
8.

Local dystrophin restoration with antisense oligonucleotide PRO051.

van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM, de Kimpe SJ, Ekhart PF, Venneker EH, Platenburg GJ, Verschuuren JJ, van Ommen GJ.

N Engl J Med. 2007 Dec 27;357(26):2677-86.

9.

Synthesis and in vitro evaluation of PNA-peptide-DETA conjugates as potential cell penetrating artificial ribonucleases.

Petersen L, de Koning MC, van Kuik-Romeijn P, Weterings J, Pol CJ, Platenburg G, Overhand M, van der Marel GA, van Boom JH.

Bioconjug Chem. 2004 May-Jun;15(3):576-82.

PMID:
15149186
10.

Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies.

Chen D, Ueda R, Harding F, Patil N, Mao Y, Kurahara C, Platenburg G, Huang M.

Eur J Immunol. 2003 Jan;33(1):172-82.

11.

Generation of transgenic mice and germline transmission of a mammalian artificial chromosome introduced into embryos by pronuclear microinjection.

Co DO, Borowski AH, Leung JD, van der Kaa J, Hengst S, Platenburg GJ, Pieper FR, Perez CF, Jirik FR, Drayer JI.

Chromosome Res. 2000;8(3):183-91.

PMID:
10841045
12.

Production of recombinant human type I procollagen homotrimer in the mammary gland of transgenic mice.

Toman PD, Pieper F, Sakai N, Karatzas C, Platenburg E, de Wit I, Samuel C, Dekker A, Daniels GA, Berg RA, Platenburg GJ.

Transgenic Res. 1999;8(6):415-27.

PMID:
10767986
13.

High-level expression of bovine alpha s1-casein in milk of transgenic mice.

Rijnkels M, Kooiman PM, Platenburg GJ, van Dixhoorn M, Nuijens JH, de Boer HA, Pieper FR.

Transgenic Res. 1998 Jan;7(1):5-14.

PMID:
9556911
14.

Mammary gland-specific hypomethylation of Hpa II sites flanking the bovine alpha S1-casein gene.

Platenburg GJ, Vollebregt EJ, Karatzas CN, Kootwijk EP, De Boer HA, Strijker R.

Transgenic Res. 1996 Nov;5(6):421-31.

PMID:
8840525
15.

Expression of human lactoferrin in milk of transgenic mice.

Platenburg GJ, Kootwijk EP, Kooiman PM, Woloshuk SL, Nuijens JH, Krimpenfort PJ, Pieper FR, de Boer HA, Strijker R.

Transgenic Res. 1994 Mar;3(2):99-108.

PMID:
8193642
16.

Generation of transgenic dairy cattle using 'in vitro' embryo production.

Krimpenfort P, Rademakers A, Eyestone W, van der Schans A, van den Broek S, Kooiman P, Kootwijk E, Platenburg G, Pieper F, Strijker R, et al.

Biotechnology (N Y). 1991 Sep;9(9):844-7.

PMID:
1367358
17.

Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells.

Kooistra T, van den Berg J, Töns A, Platenburg G, Rijken DC, van den Berg E.

Biochem J. 1987 Nov 1;247(3):605-12. Erratum in: Biochem J 1988 Mar 15;250(3):following 934.

Supplemental Content

Loading ...
Support Center